OBJECTIVE: To compare self-reported (SR) medication use and pharmacy data for major psychoactive medications and three classes of medications used for different indications, and to determine the socio-economic factors associated with the congruence. METHODS: Postal questionnaire data collected in 1997 were compared with the register of the Social Insurance Institution of Finland on the reimbursed prescriptions purchased during 1997. Altogether 7625 subjects were included in this study. Drugs were categorized according to the Anatomical Therapeutic Chemical (ATC) system. RESULTS: Kappa values were 0.77, 0.68, 0.84, 0.92 and 0.55 for antipsychotics, antidepressants, antiepileptics, antidiabetics and beta-blocking agents, respectively. Prevalence-adjusted and bias-adjusted kappa values were almost perfect (0.98-1.00). Reliability of antipsychotics use was better for married subjects than for those who were not married; and of antidepressants use for highly educated and married subjects than for those who were less educated and were not married. Altogether 414 (5.4%) responders and 285 (7.1%) non-responders had used at least one of the selected medications. CONCLUSION: Agreement between the SR and pharmacy data was moderate for psychoactive medication use. Even though data collected by postal questionnaire may underestimate the prevalence of medication use due to non-participation it can be assumed accurate enough for study purposes.
OBJECTIVE: To compare self-reported (SR) medication use and pharmacy data for major psychoactive medications and three classes of medications used for different indications, and to determine the socio-economic factors associated with the congruence. METHODS: Postal questionnaire data collected in 1997 were compared with the register of the Social Insurance Institution of Finland on the reimbursed prescriptions purchased during 1997. Altogether 7625 subjects were included in this study. Drugs were categorized according to the Anatomical Therapeutic Chemical (ATC) system. RESULTS: Kappa values were 0.77, 0.68, 0.84, 0.92 and 0.55 for antipsychotics, antidepressants, antiepileptics, antidiabetics and beta-blocking agents, respectively. Prevalence-adjusted and bias-adjusted kappa values were almost perfect (0.98-1.00). Reliability of antipsychotics use was better for married subjects than for those who were not married; and of antidepressants use for highly educated and married subjects than for those who were less educated and were not married. Altogether 414 (5.4%) responders and 285 (7.1%) non-responders had used at least one of the selected medications. CONCLUSION: Agreement between the SR and pharmacy data was moderate for psychoactive medication use. Even though data collected by postal questionnaire may underestimate the prevalence of medication use due to non-participation it can be assumed accurate enough for study purposes.
Authors: Taco B M Monster; Wilbert M T Janssen; Paul E de Jong; Lolkje T W de Jong-van den Berg Journal: Pharmacoepidemiol Drug Saf Date: 2002 Jul-Aug Impact factor: 2.890
Authors: Jeffrey R Curtis; Andrew O Westfall; Jeroan Allison; Allison Freeman; Stacey H Kovac; Kenneth G Saag Journal: Pharmacoepidemiol Drug Saf Date: 2006-10 Impact factor: 2.890
Authors: Matthew J Czarny; Erin Arthurs; Diana-Frances Coffie; Cheri Smith; Russell J Steele; Roy C Ziegelstein; Brett D Thombs Journal: PLoS One Date: 2011-11-22 Impact factor: 3.240
Authors: Anja P Husa; Jani Moilanen; Graham K Murray; Riikka Marttila; Marianne Haapea; Irina Rannikko; Jennifer H Barnett; Peter B Jones; Matti Isohanni; Anne M Remes; Hannu Koponen; Jouko Miettunen; Erika Jääskeläinen Journal: Psychiatry Res Date: 2016-11-12 Impact factor: 3.222
Authors: Jonathan D Hafferty; Archie I Campbell; Lauren B Navrady; Mark J Adams; Donald MacIntyre; Stephen M Lawrie; Kristin Nicodemus; David J Porteous; Andrew M McIntosh Journal: J Clin Epidemiol Date: 2017-10-31 Impact factor: 7.407
Authors: Päivi H Rauma; Heli Koivumaa-Honkanen; Heikki Kröger; Marjo T Tuppurainen; Jussi Kauhanen; Risto J Honkanen Journal: BMC Psychiatry Date: 2013-07-02 Impact factor: 3.630
Authors: Rahmat Sediq; Jurjen van der Schans; Aafje Dotinga; Rolinde A Alingh; Bob Wilffert; Jens Hj Bos; Catharina Cm Schuiling-Veninga; Eelko Hak Journal: Clin Epidemiol Date: 2018-08-16 Impact factor: 4.790